Serial 86585881
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Jan 2026)
What this means for you
Registered since 26 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86585881
- Registration number
- 5921153
- Mark type
- Design / logo
- Filed
- 02 Apr 2015
- Published for opposition
- 31 May 2016
- Registered
- 26 Nov 2019
- Attorney of record
- John M. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Drugs for medical purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraines and cosmetic diseases; medicines for human purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; vaccines for human purpose; vaccines for immunization against cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; Immunomodulatory drug; Antibiotics; Arthritic drug; Muscle relaxants; Anticancer agent; Drug for breast cancer; Drugs for clinical trials for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; diagnostic preparations for medical purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; diagnostic biomarker reagents for medical purposes; Medical imaging agents; fungicides; disinfectants for sanitary purposes; germicides; Anti-Clotting Agents; Antiviral agents; Monoclonal antibody; Active pharmaceutical ingredient for drugs for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; Anticonvulsants; nervines; adjuvants for medical purposes; albuminous preparations for medical purposes; bacterial preparations for medical and veterinary use; biocides; biological preparations for medical purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; biological tissue cultures for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; chemical preparations for medical purposes, namely, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; chemical reagents for medical or veterinary purposes, for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; chemico-pharmaceutical preparations for the treatment of cancers, dystonic spasms, strabismus, axillary hyperhidrosis, migraine and cosmetic diseases; enzyme preparations for medical purposes; enzymes for medical purposes; ferments for pharmaceutical purposes; hormones for medical purposes
- Class 042 — Scientific and technological services: Biological research; Bacteriological research; Clinical Research, namely, conducting clinical trials for others; Chemical Analysis
Owner
- AMARAN BIOTECHNOLOGY, INC., Zhubei City, TW
- AMARAN BIOTECHNOLOGY, INC., Taipei City, 10492, TW
- AMARAN BIOTECHNOLOGY, INC., Taipei City, 10492, TW
Prosecution history
- 06 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 12 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE